Alcohol
Volume 25, Issue 2 , Pages 59-67 , October 2001

High prevalence of hyperhomocysteinemia in chronic alcoholism: the importance of the thermolabile form of the enzyme methylenetetrahydrofolate reductase (MTHFR)

  • Marı́a J de la Vega

      Affiliations

    • Servicio de Laboratorio, Hospital Universitario de Canarias, Universidad de La Laguna, 38320, Tenerife, Spain
    • ,
  • Francisco Santolaria

      Affiliations

    • Servicio de Medicina Interna, Hospital Universitario de Canarias, Universidad de La Laguna, 38320, Tenerife, Spain
    • Corresponding Author InformationCorresponding author. Tel.: +34-922-286222; fax: +34-922-653808
    • ,
  • Emilio González-Reimers

      Affiliations

    • Servicio de Medicina Interna, Hospital Universitario de Canarias, Universidad de La Laguna, 38320, Tenerife, Spain
    • ,
  • Marı́a R Alemán

      Affiliations

    • Servicio de Medicina Interna, Hospital Universitario de Canarias, Universidad de La Laguna, 38320, Tenerife, Spain
    • ,
  • Antonio Milena

      Affiliations

    • Servicio de Laboratorio, Hospital Universitario de Canarias, Universidad de La Laguna, 38320, Tenerife, Spain
    • ,
  • Antonio Martı́nez-Riera

      Affiliations

    • Servicio de Medicina Interna, Hospital Universitario de Canarias, Universidad de La Laguna, 38320, Tenerife, Spain
    • ,
  • Cándido González-Garcı́a

      Affiliations

    • Servicio de Laboratorio, Hospital Universitario de Canarias, Universidad de La Laguna, 38320, Tenerife, Spain

Received 25 July 2000 ,Revised 23 March 2001 ,Accepted 16 May 2001.

References 

  1. Beghi E, Boglium G, Cosso P, Fiorelli G, Lorini C, Mandelli M, et al. Stroke and alcohol intake in a hospital population: a case-control study. Stroke. 1995;26:1691–1696
  2. Blackburn GL, Bistrian BR, Maini BS, Schlamm HT, Smith MF. Nutritional and metabolic assessment of the hospitalized patient. JPEN (J Parenter Enteral Nutr). 1977;1:11–22
  3. Blackwelder WC, Yano K, Rhoads GG, Kagan A, Gordon T, Palesch Y. Alcohol and mortality: the Honolulu Heart Study. Am J Med. 1980;68:164–169
  4. Bleich S, Degner D, Wiltfang J, Maler JM, Niedmann P, Cohrs S, et al. Elevated homocysteine levels in alcohol withdrawal. Alcohol Alcohol. 2000;35:351–354
  5. Blocker DE, Thenen SW. Intestinal absorption, liver uptake, and excretion of 3H-folic acid in folic acid–deficient, alcohol-consuming nonhuman primates. Am J Clin Nutr. 1987;46:503–510
  6. Brattstrom L, Zhang Y, Hurtig M, Refsum H, Ostensson S, Fransson L, et al. A common methylenetetrahydrofolate reductase gene mutation and longevity. Atherosclerosis. 1998;141:315–319
  7. Bronstrup A, Hages M, Prinz-Langenohl R, Pietrzik K. Effects of folic acid and combinations of folic acid and vitamin B-12 on plasma homocysteine concentrations in healthy, young women. Am J Clin Nutr. 1998;68:1104–1110
  8. Camargo CA, Hennekens CH, Gaziano JM, Glynn RJ, Manson JE, Stampfer MJ. Prospective study of moderate alcohol consumption and mortality in US male physicians. Arch Intern Med. 1997;157:79–85
  9. Chait A, Malinow MR, Nevin DN, Morris CD, Eastgard RL, Kris-Etherton P, et al. Increased dietary micronutrients decrease serum homocysteine concentrations in patients at high risk of cardiovascular disease. Am J Clin Nutr. 1999;70:881–887
  10. Cordoba PA, Cirera S, Carrascosa C, Arcelus R, Castellvi A, Rodes M. Thermolabile genotype of methylene tetrahydrofolate reductase and hyperhomocysteinemia in patients with non hemorragic cerebro-vascular disease. J Inherit Metab Dis. 1996;19(suppl. 1):23
  11. Cravo ML, Gloria LM, Selhub J, Nadeau MR, Camilo ME, Resende MP, et al. Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status. Am J Clin Nutr. 1996;63:220–224
  12. Deloughery TG, Evans A, Sadeghi A, McWilliams J, Henner WD, Taylor LM, et al. Common mutation in methylenetetrahydrofolate reductase: correlation with homocysteine metabolism and late-onset vascular disease. Circulation. 1996;94:3074–3078
  13. den Heijer M, Rosendaal FR, Blom HJ, Gerrits WB, Bos GM. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost. 1998;80:874–877
  14. Fernando OV, Grimsley EW. Prevalence of folate deficiency and macrocytosis in patients with and without alcohol-related illness. South Med J. 1998;91:721–725
  15. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111–113
  16. Gill JS, Shipley MJ, Tsementzis SA, Hornby RS, Gill SK, Hitchcock ER, et al. Alcohol consumption—a risk factor for hemorrhagic and non-hemorrhagic stroke. Am J Med. 1991;90:489–497
  17. Gloria L, Cravo M, Camilo ME, Resende M, Cardoso JN, Oliveira AG, et al. Nutritional deficiencies in chronic alcoholics: relation to dietary intake and alcohol consumption. Am J Gastroenterol. 1997;92:485–489
  18. González-Hermoso F, Porta R, Herrero A. Resultados del estudio antropométrico de la población canaria adulta. Nutr Hosp. 1990;5:238–247
  19. Guttormsen AB, Ueland PM, Nesthus I, Nygard O, Schneede J, Vollset SE, et al. Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (>or= 40 micromol/liter): the Hordaland Homocysteine Study. J Clin Invest. 1996;98:2174–2183
  20. Hernández-Plasencia D, Santolaria F, Hernández-Garcı́a M, González-Reimers E, Batista N, Jorge J, et al. Subjective nutritional assessment and short term prognosis. J Nutr Med. 1991;2:151–162
  21. Hillers VN, Massey LK. Interrelationships of moderate and high alcohol consumption with diet and health status. Am J Clin Nutr. 1985;41:356–362
  22. Hultberg B, Berglund M, Andersson A, Frank A. Elevated plasma homocysteine in alcoholics. Alcohol Clin Exp Res. 1993;17:687–689
  23. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7–9
  24. Kang SS, Wong PW, Norusis M. Homocysteinemia due to folate deficiency. Metabolism. 1987;36:458–462
  25. Kang SS, Wong PW, Zhou JM, Sora J, Lessick M, Ruggie N, et al. Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease. Metabolism. 1988;37:611–613
  26. Kazanawa S, Herbert V. Total corrinoid, cobalamin (vitamin B12), and cobalamin analogue levels may be normal in serum despite cobalamin in liver depletion in patients with alcoholism. Lab Invest. 1985;53:108–110
  27. Kenyon SH, Nicolaou A, Gibbons WA. The effect of ethanol and its metabolites upon methionine synthase activity in vitro. Alcohol. 1998;15:305–309
  28. Lambert D, Benhayoun S, Adjalla C, Gelot MM, Renkes P, Gerard P, et al. Alcoholic cirrhosis and cobalamin metabolism. Digestion. 1997;58:64–71
  29. Leevy CM, Baker H, tenHove W, Frank O, Cherrik GR. B complex vitamins in liver disease of the alcoholic. Am J Clin Nutr. 1965;16:339–346
  30. Leppala JM, Paunio M, Virtamo J, Fogelholm R, Albanes D, Taylor PR, et al. Alcohol consumption and stroke incidence in male smokers. Circulation. 1999;100:1209–1214
  31. Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, et al. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation. 1996;94:2410–2416
  32. Malinow MR, Nieto FJ, Kruger WD, Duell PB, Hess DL, Gluckman RA, et al. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol. 1997;17:1157–1162
  33. Markus HS, Ali N, Swaminathan R, Sankaralingam A, Molloy J, Powell J. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. Stroke. 1997;28:1739–1743
  34. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969;56:111–128
  35. McMartin KE, Collins TD, Shiao CQ, Vidrine L, Redetzki HM. Study of dose-dependence and urinary folate excretion produced by ethanol in humans and rats. Alcohol Clin Exp Res. 1986;10:419–424
  36. McMartin KE, Shiao CQ, Collins TD, Redetzki HM. Acute ethanol ingestion by humans and subacute treatment of rats increase urinary folate excretion. Alcohol. 1985;2:473–477
  37. Pancharuniti N, Lewis CA, Sauberlich HE, Perkins LL, Go RC, Alvarez JO, et al. Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr. 1994;59:940–948
  38. Robinson K, Arheart K, Refsum H, Brattstrom L, Boers G, Ueland P, et al. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease [European COMAC Group]. Circulation. 1998;97:437–443
  39. Robinson K, Mayer EL, Miller DP, Green R, van Lente F, Gupta A, et al. Hyperhomocysteinemia and low pyridoxal phosphate: common and independent reversible risk factors for coronary artery disease. Circulation. 1995;92:2825–2830
  40. Russell RM, Rosenberg IH, Wilson PD, Iber FL, Oaks EB, Giovetti AC, et al. Increased urinary excretion and prolonged turnover time of folic acid during ethanol ingestion. Am J Clin Nutr. 1983;38:64–70
  41. Santolaria F, González-González G, González-Reimers E, Martinez-Riera A, Milena A, Rodrı́guez-Moreno F, et al. Effects of alcohol and liver cirrhosis on the GH-IGF-I axis. Alcohol Alcohol. 1995;30:703–708
  42. Santolaria F, Perez-Manzano JL, Milena A, González-Reimers E, Gomez-Rodrı́guez MA, Martı́nez-Riera A, et al. Nutritional assessment in alcoholic patients: its relationship with alcoholic intake, feeding habits, organic complications and social problems. Drug Alcohol Depend. 2000;59:295–304
  43. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PW, Belanger AJ, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 1995;332:286–291
  44. Schipchandler MT, Moore EG. Rapid, fully automated measurement of plasma homocyst(e)ine with Abbott IMxR analyzer. Clin Chem. 1995;41:991–994
  45. Siri PW, Verhoef P, Kok FJ. Vitamins B6, B12, and folate: association with plasma total homocysteine and risk of coronary atherosclerosis. J Am Coll Nutr. 1998;17:435–441
  46. Stickel F, Choi SW, Kim YI, Bagley PJ, Seitz HK, Russell RM, et al. Effect of chronic alcohol consumption on total plasma homocysteine level in rats. Alcohol Clin Exp Res. 2000;24:259–264
  47. Tokgozoglu SL, Alikasifoglu M, Unsal I, Atalar E, Aytemir K, Ozer N, et al. Methylene tetrahydrofolate reductase genotype and the risk and extent of coronary artery disease in a population with low plasma folate. Heart. 1999;81:518–522
  48. Tormo A, Santolaria F, González-Reimers E, Oramas J, Rodrı́guez-Rodrı́guez E, Rodrı́guez-Moreno F, et al. Short-term prognostic value of subjective nutritional assessment in general medical patients. J Nutr Med. 1994;4:287–295
  49. Tucker KL, Selhub J, Wilson PW, Rosenberg IH. Dietary intake pattern relates to plasma folate and homocysteine concentrations in the Framingham Heart Study. J Nutr. 1996;126:3025–3031
  50. Ubbink JB, Vermaak WJ, van der Merwe A, Becker PJ. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr. 1993;57:47–53
  51. Verhoef P, Meleady R, Daly LE, Graham IM, Robinson K, Boers GH. Homocysteine, vitamin status and risk of vascular disease: effects of gender and menopausal status [European COMAC Group]. Eur Heart J. 1999;20:1234–1244

PII: S0741-8329(01)00167-7

Alcohol
Volume 25, Issue 2 , Pages 59-67 , October 2001

Article Tools

* Image Usage & Resolution